Yeast and fungal beta-glucan
Yeast Beta-(1,3/1,6)-D-Glucan · also known as Yeast glucan, Fungal polysaccharide, Beta-1,3/1,6-D-glucan
Yeast beta-glucan is recognized by the Dectin-1 receptor, which then activates macrophages and neutrophils. After oral intake, the evidence for signal activation and trained immunity in humans rests only on small studies of transcriptional markers, and it still needs confirming.
Clinical uses and human evidence
Colds: prevention and duration
Studies (2)
- Zhong 2021 · Eur J Nutr · Meta-analysis — Effects of yeast β-glucans for the prevention and treatment of upper respiratory tract infection in healthy subjects: a systematic review and meta-analysis
- Habibullah 2026 · iScience · RCT · n=198 — Low-dose of yeast beta-glucan on respiratory symptoms and psychological well-being in moderately stressed adults
Anxiety and stress
Low mood
Mechanisms of action
Pattern recognition receptor (PRR) immune surveillance and trained immunity
Recognition of yeast beta-glucan by Dectin-1 is its core mechanism. Activation of the Syk-CARD9 pathway and trained immunity after oral intake in humans remain to be verified. A small placebo-controlled trial in 19 people measured changes in only some related transcripts.
Colonic short-chain fatty acid (SCFA/butyrate) fermentation substrate and receptor activation
In mouse experiments, some yeast polysaccharides can change the gut microbiota and fecal short-chain fatty acids, and results vary by formulation. An exploratory human trial did not observe significant changes in fecal short-chain fatty acids, so yeast beta-glucan should not be regarded as a reliable source of short-chain fatty acids.
Safety and drug interactions
Immune stimulation
Activates innate immune cells. Each of these stimulates immune responses. They may counteract immunosuppressant drugs, and caution is also needed during active autoimmune disease.